My first internship at the World Health Organisation – A formative experience and an education in the value of community-based​ medicine

In the most remote regions of the African continent, where healthcare centers and clinics are few and far between; where a journey on foot or on a bicycle to the nearest healthcare facility can easily last an entire day in the merciless, blistering heat of the sub-Saharan sun; too many children below the age of ...

I am an African.

Here is a very uncharacteristic piece. Uncharacteristic as it is neither related to health or development. At least not directly. As the month of May has drawn to an end – I have reflected upon what May 2019 meant to me. I recall one of my favourite speeches – and most profound in its timing. Delivered ...

What are Clinical Trials ?

If your aim is to gain a bare bones understanding of clinical trials in 5 minutes or less, this is for you. Here I will explain what clinical trials are, some basic history, changes that have been made to effectuate what are called the ‘best’ clinical trials. There will be a part two to this ...

Human Rights Council – 40th Regular Session

The Office for the United Nations High Commission on Human Rights (OHCHR) Human Rights Council is still ongoing this week! As a teen, I recall taking time off class with my student newspaper press pass with some fellow, editor colleagues to attend HRC sessions. If you haven’t been following – including the few walkouts during ...

Life Cycle Management: An ‘Insider’s’ guide on how to make your drug last FOREVER $$$

A CASE STUDY In the pharmaceutical and biotechnology industries, there is a critical point in dealing with your novel agent when it becomes vital to have a clear and cohesive strategy as to how to manage and optimize the life of said drug, agent or device! Namely, ahead of introduction to the market. So, just ...

Why Investors in the Pharmaceutical Industry Should Start Investing in Diseases Affecting Poor Countries.

Let’s discuss why investors in the pharmaceutical industry should start investing in drugs, therapeutics and medical devices aimed at treating, managing and ameliorating diseases affecting middle income countries in particular and the ‘global south’ in general.

Why everyone has fewer children today than ever before

Child survival. The dramatic improvement in child survival globally has brought babies per woman to as low as 2.2 in Bangladesh; 2.3 in India and 3.97 in Ethiopia. These are not anomalies. This is the norm. Furthermore, in cities, such as the Ethiopian capital of Addis Ababa, the number of babies per woman is less ...

Browse Categories